Cytolytic T cell lines which bind to complexes of tumor rejectio

Details Cytolytic T cell lines which bind to complexes of tumor rejectio Cytolytic T cell lines which bind to complexes of tumor rejectio

1997-02-06

1998-04-28

Caputa, Anthony C.

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

4353723, C12N 506

Patent

active

057443530

ABSTRACT:
Tumor rejection antigens presented by HLA-B44 molecules are described. These peptides are useful in diagnostic and therapeutic methodologies. The tumor rejection antigens are derived from MAGE tumor rejection antigen precursors.

REFERENCES:
patent: 5405940 (1995-04-01), Boon et al.
Tiercy et al. Human Immunology 41:207-15, 1994.
Salgaller et al. Cancer Immunol. Immunother. 39:105-116, Aug. 1994.
Fleischauer et al. Tissue Antigens 311-17, 1994.

Affiliated with

Also associated with

Rating

Cytolytic T cell lines which bind to complexes of tumor rejectio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytolytic T cell lines which bind to complexes of tumor rejectio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytolytic T cell lines which bind to complexes of tumor rejectio will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1531291